Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

The standard of care for patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancer is endocrine therapy. Endocrine agents, including aromatase inhibitors, tamoxifen, and fulvestrant, are often administered alone as first line treatment and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Med
Hlavní autoři: Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350905/
https://ncbi.nlm.nih.gov/pubmed/25857348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0280-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky